Literature DB >> 25696659

Do patients benefit from drug-eluting stents in acute myocardial infarction?

R F R Steens, J W Jukema, E E van der Wall.   

Abstract

Entities:  

Year:  2006        PMID： 25696659      PMCID： PMC2557284     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  9 in total

1.  Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

Authors:  Raúl Moreno; Cristina Fernández; Rosana Hernández; Fernando Alfonso; Dominick J Angiolillo; Manel Sabaté; Javier Escaned; Camino Bañuelos; Antonio Fernández-Ortiz; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

2.  Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Authors:  Pramod K Kuchulakanti; William W Chu; Rebecca Torguson; Patrick Ohlmann; Seung-Woon Rha; Leonardo C Clavijo; Sang-Wook Kim; Ahn Bui; Natalie Gevorkian; Zhenyi Xue; Kimberly Smith; Jana Fournadjieva; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

Review 3.  Drug-eluting stents: results, promises and problems.

Authors:  Barend L van der Hoeven; Nuno M M Pires; Hazem M Warda; Pranobe V Oemrawsingh; Bart J M van Vlijmen; Paul H A Quax; Martin J Schalij; Ernst E van der Wall; J Wouter Jukema
Journal:  Int J Cardiol       Date:  2005-03-10       Impact factor: 4.164

4.  Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.

Authors:  A Bagust; A D Grayson; N D Palmer; R A Perry; T Walley
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

5.  Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.

Authors:  Andrew T L Ong; Angela Hoye; Jiro Aoki; Carlos A G van Mieghem; Gaston A Rodriguez Granillo; Karel Sonnenschein; Evelyn Regar; Eugene P McFadden; Georgios Sianos; Willem J van der Giessen; Peter P T de Jaegere; Pim de Feyter; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

6.  Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.

Authors:  Seung-Whan Lee; Seong-Wook Park; Myeong-Ki Hong; Young-Hak Kim; Bong-Ki Lee; Jong-Min Song; Ki Hoon Han; Cheol Whan Lee; Duk-Hyun Kang; Jae-Kwan Song; Jae-Joong Kim; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2005-10-19       Impact factor: 24.094

7.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

Authors:  Ioannis Iakovou; Thomas Schmidt; Erminio Bonizzoni; Lei Ge; Giuseppe M Sangiorgi; Goran Stankovic; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Mauro Carlino; Iassen Michev; Nicola Corvaja; Carlo Briguori; Ulrich Gerckens; Eberhard Grube; Antonio Colombo
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

8.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction.

Authors:  Weon Kim; Myung Ho Jeong; Kye Hun Kim; Il Suk Sohn; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Dong Lyun Cho; Jung Chae Kang
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.